PL375487A1 - Miejscowe leczenie chorób skóry - Google Patents

Miejscowe leczenie chorób skóry

Info

Publication number
PL375487A1
PL375487A1 PL03375487A PL37548703A PL375487A1 PL 375487 A1 PL375487 A1 PL 375487A1 PL 03375487 A PL03375487 A PL 03375487A PL 37548703 A PL37548703 A PL 37548703A PL 375487 A1 PL375487 A1 PL 375487A1
Authority
PL
Poland
Prior art keywords
skin diseases
topical treatment
topical
treatment
diseases
Prior art date
Application number
PL03375487A
Other languages
English (en)
Inventor
Chris Rundfeldt
Manfred Kietzmann
Joachim Hoppmann
Wolfgang Bäumer
Hildegard Kuss
Norbert Höfgen
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elbion Ag filed Critical Elbion Ag
Publication of PL375487A1 publication Critical patent/PL375487A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL03375487A 2002-07-11 2003-07-10 Miejscowe leczenie chorób skóry PL375487A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39522102P 2002-07-11 2002-07-11

Publications (1)

Publication Number Publication Date
PL375487A1 true PL375487A1 (pl) 2005-11-28

Family

ID=30115840

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375487A PL375487A1 (pl) 2002-07-11 2003-07-10 Miejscowe leczenie chorób skóry

Country Status (20)

Country Link
US (1) US20040038958A1 (pl)
EP (1) EP1531818A1 (pl)
JP (1) JP2005537262A (pl)
KR (1) KR20050021464A (pl)
CN (1) CN1681500A (pl)
AR (1) AR040647A1 (pl)
AU (1) AU2003254332B2 (pl)
BR (1) BR0312696A (pl)
CA (1) CA2492093A1 (pl)
HR (1) HRP20050133A2 (pl)
IL (1) IL166016A0 (pl)
MX (1) MXPA05000486A (pl)
NO (1) NO20050718L (pl)
NZ (1) NZ537482A (pl)
PL (1) PL375487A1 (pl)
RU (1) RU2005103608A (pl)
TW (1) TW200410690A (pl)
UA (1) UA80711C2 (pl)
WO (1) WO2004006920A1 (pl)
ZA (1) ZA200500108B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546142A4 (en) 2002-08-29 2007-10-17 Merck & Co Inc INDOLES HAVING ANTIDIABETIC EFFECT
CN100457730C (zh) 2002-08-29 2009-02-04 默克公司 具有抗糖尿病活性的吲哚化合物
WO2004107678A2 (en) * 2003-05-28 2004-12-09 Artimi Ltd Ultra-wideband network, device, device controller, method and data packet for establishing a mesh network and forwarding packets on another channel
EP1713471B1 (en) * 2004-02-06 2012-01-18 MEDA Pharma GmbH & Co. KG Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
ES2413011T3 (es) * 2004-02-06 2013-07-15 Meda Pharma Gmbh & Co. Kg Combinación de anticolinérgicos y glucocorticoides para el tratamiento a largo plazo de asma y EPOC
JP4961131B2 (ja) * 2004-10-29 2012-06-27 田辺三菱製薬株式会社 皮膚損傷治療剤
TWI339578B (en) * 2004-10-29 2011-04-01 Mitsubishi Tanabe Pharma Corp Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
EP1863476B1 (en) * 2005-03-16 2016-02-03 MEDA Pharma GmbH & Co. KG The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
NZ591969A (en) * 2005-12-21 2012-05-25 Meda Pharma Gmbh & Co Kg Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases
US7645752B2 (en) * 2006-01-13 2010-01-12 Wyeth Llc Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors
AU2007218725B2 (en) 2006-02-21 2011-12-01 Eisai R & D Management Co., Ltd. 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
US8530654B2 (en) 2007-02-16 2013-09-10 Eisai R&D Management Co., Ltd. Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
CA2696793A1 (en) 2007-08-17 2009-02-26 Eisai R&D Management Co., Ltd. Novel preparation for external use
JOP20130213B1 (ar) 2012-07-17 2021-08-17 Takeda Pharmaceuticals Co معارضات لمستقبلht3-5
CA2962429C (en) 2014-09-29 2023-01-03 Takeda Pharmaceutical Company Limited Crystalline form of 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indole-3-carboxamide
CA3010615C (en) 2016-01-14 2024-02-20 Beth Israel Deaconess Medical Center, Inc. Mast-cell modulators and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341783A (en) * 1980-07-31 1982-07-27 Lemmon Company Topical use of dyphylline and dyphylline containing compositions
AU6821294A (en) * 1993-04-30 1994-11-21 Rodner R. Winget Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
PL198983B1 (pl) * 1998-04-28 2008-08-29 Elbion Ag Nowe hydroksyindole, ich zastosowanie jako inhibitorów fosfodiesterazy 4 oraz sposoby ich wytwarzania

Also Published As

Publication number Publication date
AU2003254332B2 (en) 2009-01-08
CA2492093A1 (en) 2004-01-22
CN1681500A (zh) 2005-10-12
AR040647A1 (es) 2005-04-13
MXPA05000486A (es) 2005-07-22
NZ537482A (en) 2006-09-29
TW200410690A (en) 2004-07-01
ZA200500108B (en) 2005-02-23
BR0312696A (pt) 2005-04-26
NO20050718L (no) 2005-04-01
RU2005103608A (ru) 2005-06-27
UA80711C2 (en) 2007-10-25
US20040038958A1 (en) 2004-02-26
EP1531818A1 (en) 2005-05-25
KR20050021464A (ko) 2005-03-07
IL166016A0 (en) 2006-01-15
HRP20050133A2 (en) 2005-04-30
JP2005537262A (ja) 2005-12-08
WO2004006920A1 (en) 2004-01-22
AU2003254332A1 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
AU2003278775A8 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
GB0612417D0 (en) Compositions and methods for topical treatment of skin infection
AU2003265225A8 (en) Preparations for topical skin use and treatment
AU2003286567A8 (en) Methods for the treatment of skin disorders
IL169338A0 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
GB0201850D0 (en) Therapeutic treatment
IL166016A0 (en) Topical treatment of skin diseases
ZA200410401B (en) Use of thio-oxindole derivatives in treatment of skin disorders
AUPQ877300A0 (en) Topical treatment of skin
EP1636160A4 (en) NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLISM AND SKIN DISEASES
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
EP1648399A4 (en) METHOD AND TOPIC COMPOSITION FOR TREATING SKIN HYPERPIGMENTATION
GB0211295D0 (en) Treatment of pain
AU2003251407A8 (en) Topical treatment for skin irritation
AU2003256447A1 (en) Treatment of autoimmune skin diseases
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
GB0210464D0 (en) Therapeutic treatment
GB0101146D0 (en) Treatment of skin conditions
AU2003297570A1 (en) Treatment of skin diseases
AU2003273247A1 (en) Non-invasive methods to identify agents for treating pain
HK1071692A (en) Topical treatment of skin diseases
AU2003237742A1 (en) Composition for the treatment of skin diseases and for improving hair growth
AU2002365654A8 (en) Treatment of diseases via the skin
GB0208183D0 (en) Treatment of skin conditions

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)